EKF at AACC - Anaheim, California 2019
Details
AACC Annual Scientific Meeting & Clinical Lab Expo
Anaheim, Ca | Exhibition dates 6-8 August, 2019
Stand number #2952
Venue: Anaheim Convention Centre
Web: www.aacc.org
71st AACC Annual Scientific Meeting & Clinical Lab Expo
At the 71st AACC Annual Scientific Meeting & Clinical Lab Expo, you’ll have the opportunity to:
- Connect with global leaders in clinical chemistry, molecular diagnostics, mass spectrometry, translational medicine, lab management, and other areas of breaking science in laboratory medicine.
- Learn about cutting edge technology. The AACC Clinical Lab Expo has more than 200 new product introductions each year.
- Hear vital research and learn about important changes in the field. With nearly 300 educational opportunities in the form of lectures, plenary sessions, scientific sessions, and roundtable sessions, you can design an educational experience that meets your need to stay ahead of changes in the field.
Products on display
Mr. Takuji Kohzuma
Mr Takuji Kohzuma Ph.D. Senior Manager, IVD Kit Product Group from Asahi Kasei Pharma is the inventor of the enzymatic method for Glycated Albumin and will be on our booth at AACC.
Mr Kohzuma has worked for Asahi Kasei Corp. since 1989. His career is full of achievements, several scientific reports and patents:
Company
1989 Asahi Kasei Corp.
2005 Asahi Kasei Pharma Corp.
Academic background
1987 Bachelor of Science: Kyushu University (Japan)
1989 Master of Science: Kyushu University (Japan)
2006 Doctor of Pharmacology: Kyushu University (Japan)
Career
2002 Published first report of the “Enzymatic method for Glycated Albumin” (Clin Chim Acta)
2002 A member of a “Glycated Albumin Standardization Project”, of Committee on Diabetes Mellitus indices, Japan Society of Clinical Chemistry
2005 “Prize of technology” from Japan Society of Clinical Chemistry
2008 Reported the “JSCC Recommended Method for Glycated Albumin Measurement in Serum” as one of authors of Committee” on Journal of “Rinsho Kagaku”
2014 Adviser for a “Glycated Albumin Standardization Project”, of Committee on Diabetes Mellitus indices, Japan Society of Clinical Chemistry
2015 Reported the “Reference measurement Procedure and reference materials for GA determination (Annals Clin. Biochem.)
Others（July 2019）
Scientific reports: 29, including “Diabetologia”, “Atherosclerosis”, “Clinica Chimica Acta”, etc.
Patents: 55 including 6 of international patents, ”Composition for assaying glycated protein”
EKF staff attending
Mike Salter - President, Americas
Jami Meeks – VP, Strategic Business Development
Shane O’Neill - Global Director, Scientific Affairs
Bart Battles - Sales Director, USCAN
Brian Griffin - Sales Director, USCAN Blood Bank
Sergio Stilman - Sales Director, LATAM
Allan Leest – Sales Manager, Mexico/Caribbean
Gino Rampolla – Regional Sales Manager, Southeast
Ed Balmelli – Regional Sales Manager, West
David West – Biomedical Service Manager
